Magainin Pharm (MAGN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Magainin Pharm (MAGN)

MAGN 8.890

+2.2%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Shlepper who wrote (64)	7/30/1997 5:50:00 AM
From: Kevin Stull	of 233

The tread has mirrored the quiet state of this stock. Lots of upward revisions for MAGN. Zack's now has it rated a 1 out of 5 with 1 being the highest (i.e. very good performance expectations for next 90-180 days). Something must be cooking. MAGN: COWEN & CO. has reiterated estimate for fiscal year ending 12/99 of $-0.15 on 07/28/97 MAGN: HAMBRECHT&QUIST made new estimate for fiscal year ending 12/98 of $-0.45 on 07/25/97 MAGN: HAMBRECHT&QUIST made new estimate for quarter ending 09/97 of $-0.37 on 07/25/97 MAGN: COWEN & CO. increased estimate for fiscal year ending 12/97 from $-0.75 to $-0.55 on 07/28/97 MAGN: COWEN & CO. increased estimate for fiscal year ending 12/98 from $-0.90 to $-0.40 on 07/28/97 MAGN: HAMBRECHT&QUIST decreased estimate for fiscal year ending 12/97 from $-0.45 to $-0.65 on 07/25/97 MAGN: HAMBRECHT&QUIST made new estimate for quarter ending 12/97 of $-0.21 on 07/25/97

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next